Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.03 (+8.06%)

    Market Cap: $8.14M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Ensysce Biosciences Inc (ENSC) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Ensysce Biosciences (ENSC) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Ensysce Biosciences reported EPS of -$0.13, above the -$0.19 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    67%(14/21)
    Avg Surprise
    +17.50%
    Streak
    4 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.08
    Range-$0.14 - -$0.01
    4 analysts
    Revenue Consensus
    $901.00K
    RangeN/A
    5 analysts

    Next Report

    ENSC has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, ENSC beat 14, missed 6 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.18M, up 342.1% from $493104 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.13-$0.19N/A+31.58%BeatN/A10 up, 0 downNov 12, 2026$2.18M
    Jun 30, 2026-$0.20-$0.50-$0.50 - -$0.50+60.00%BeatN/A10 up, 0 downAug 13, 2026$1.16M
    Mar 31, 2026-$0.52-$0.73-$0.73 - -$0.73+28.77%BeatN/A10 up, 0 downMay 15, 2026$960999
    Dec 31, 2025-$0.75-$1.26-$1.26 - -$1.26+40.48%BeatN/A10 up, 0 downMar 30, 2026$1.88M
    Sep 30, 2025-$1.29-$0.93-$0.93 - -$0.93-38.71%Miss-222.9%10 up, 0 downNov 14, 2025$493104
    Jun 30, 2025-$0.79-$1.28-$1.28 - -$1.28+38.28%BeatN/A10 up, 0 downAug 13, 2025$1.37M
    Mar 31, 2025-$1.39-$1.53-$1.53 - -$1.53+9.15%BeatN/A10 up, 0 downMay 13, 2025$1.32M
    Dec 31, 2024-$2.90-$1.95-$1.95 - -$1.95-48.72%MissN/A11 up, 0 downMar 10, 2025$1.30M
    Sep 30, 2024$1.05-$2.55-$6.30 - -$2.55+141.18%BeatN/A20 up, 0 downNov 12, 2024$3.42M
    Jun 30, 2024-$3.30-$5.25-$6.75 - -$4.95+37.14%BeatN/A20 up, 0 downAug 14, 2024$181797
    Mar 31, 2024-$8.25-$11.25-$15.74 - -$11.24+26.67%BeatN/A20 up, 0 downMay 10, 2024$305722
    Dec 31, 2023-$1.37-$0.87-$0.93 - -$0.81-57.47%MissN/A20 up, 0 downMar 15, 2024$515032
    Sep 30, 2023-$13.05-$15.85-$17.39 - -$13.94+17.67%BeatN/A30 up, 0 downNov 9, 2023$435380
    Jun 30, 2023-$14.46-$80.25N/A+81.98%BeatN/A30 up, 0 downAug 11, 2023$490472
    Mar 31, 2023-$36.39-$87.60-$314.84 - -$72.86+58.46%BeatN/A30 up, 0 downMay 15, 2023$789635
    Dec 31, 2022-$18.24-$28.88-$42.14 - -$20.05+36.84%BeatN/A30 up, 0 downMar 30, 2023$1.43M
    Sep 30, 2022-$578.77-$612.00N/A+5.43%BeatN/A20 up, 0 downNov 14, 2022$279351
    Jun 30, 2022-$759.02-$468.00-$755.92 - -$467.95-62.18%MissN/A20 up, 0 downAug 11, 2022$207471
    Mar 31, 2022-$729.00-$576.00-$719.93 - -$431.96-26.56%Miss-291700.0%20 up, 0 downMay 12, 2022$603098
    Dec 31, 2021-$9.00-$8.00-$31.21 - $21.61-12.50%Miss-3158.1%20 up, 0 downMar 31, 2022$1.64M
    Sep 30, 2021-$0.71-$0.71N/A0.00%In line-2466.7%N/AN/ANov 15, 2021$1.20M
    Jun 30, 2021-$0.06N/AN/AN/AN/A-115.0%N/AN/AAug 16, 2021$444516
    Mar 31, 2021$0.25N/AN/AN/AN/AN/AN/AN/AJun 7, 2021$250576
    Dec 31, 2020$0.29N/AN/AN/AN/AN/AN/AN/AMar 15, 2021$416489
    Sep 30, 2020$0.03N/AN/AN/AN/A-100.0%N/AN/ANov 9, 2020$827639
    Jun 30, 2020$0.40N/AN/AN/AN/A-99.3%N/AN/AAug 7, 2020$1.82M
    Mar 31, 2020-$0.05N/AN/AN/AN/A-100.0%N/AN/AMay 7, 2020$862400
    Dec 31, 2019-$0.06N/AN/AN/AN/AN/AN/AN/AMar 10, 2020N/A
    Sep 30, 2019$70.63N/AN/AN/AN/AN/AN/AN/ANov 7, 2019N/A
    Jun 30, 2019$60.45N/AN/AN/AN/AN/AN/AN/AAug 7, 2019N/A
    Mar 31, 2019$111.77N/AN/AN/AN/AN/AN/AN/AMay 6, 2019N/A
    Dec 31, 2018-$68.52N/AN/AN/AN/AN/AN/AN/AMar 11, 2019N/A
    Sep 30, 2018-$42.24N/AN/AN/AN/AN/AN/AN/ANov 7, 2018N/A
    Jun 30, 2018-$47.04N/AN/AN/AN/AN/AN/AN/AAug 1, 2018N/A
    Mar 31, 2018-$16.53N/AN/AN/AN/AN/AN/AN/AMay 3, 2018N/A
    Last 35 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.22, after -$13.40 the year before. It was -$174.34 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.22N/A
    Dec 31, 2024-$13.40N/A
    Dec 31, 2023-$65.27N/A
    Dec 31, 2022-$2,085.03N/A
    Dec 31, 2021-$9.52-1514.8%
    Dec 31, 2020$0.67-99.7%
    Dec 31, 2019$242.80N/A
    Dec 31, 2018-$174.34N/A

    Frequently Asked Questions About ENSC

    When is Ensysce Biosciences's next earnings date?

    Ensysce Biosciences's next earnings report is expected for Mar 29, 2027.

    Did ENSC beat earnings estimates last quarter?

    Yes. Ensysce Biosciences reported EPS of -$0.13 for the quarter ended Sep 30, 2026, above the -$0.19 estimate, a 31.58% surprise.

    What EPS do analysts expect from ENSC next quarter?

    The consensus EPS estimate for Ensysce Biosciences for the quarter ending Dec 31, 2026 is -$0.08 from 4 analysts, with estimates from -$0.14 to -$0.01.

    How often does ENSC beat earnings estimates?

    Ensysce Biosciences beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +15.10%.